Management of RPR Titer Increase from 1:4 to 1:8

Definition of Treatment Failure

• The CDC defines serologic treatment failure for syphilis as a ≥4‑fold (two‑dilution) increase in nontreponemal titers; a change from 1:4 to 1:8 represents only a 2‑fold (one‑dilution) rise and therefore does not meet the failure threshold, so retreatment is not indicated. 1

Clinical Evaluation

• Presence of neurologic signs (e.g., cranial nerve deficits, altered mental status, auditory changes), ophthalmic manifestations (uveitis, iritis), or evidence of tertiary disease (aortitis, gumma) mandates cerebrospinal fluid (CSF) examination regardless of the magnitude of titer change. 1
• Although HIV‑infected individuals may exhibit different serologic response patterns, the definition of treatment failure remains the same (≥4‑fold increase). 4

Follow‑up Monitoring Schedule

• After initial therapy, quantitative RPR testing should be repeated at 6, 12, and 24 months to track serologic response. 1
• Expected serologic decline is a ≥4‑fold reduction from baseline within 12–24 months for latent syphilis or within 6–12 months for early syphilis. 5

Criteria Triggering CSF Examination and Retreatment

• Retreatment and CSF evaluation are indicated if any of the following occur:

Retreatment Recommendations and Efficacy

• When the above failure criteria are met, retreatment for latent syphilis should be initiated even if CSF results are negative. 1
• Additional penicillin doses do not provide increased efficacy for early syphilis, irrespective of HIV status. 1